Key takeaways for me13 Oct 2021 11:26
£250k is less than expected, but its just a nominal fee, its like paying £1 for a house in Newcastle(I know, 99p too much..) as part of a government regeneration project, you HAVE to pay something to buy it, but Eli have spent millions to date on CDX so its a nice gesture to hand over more than a quid.
Eli name drop - FINALLY, it was getting stupid having to keep telling people that Global Co is eli lilly............
Big one is this line: "In addition, the Company will pay Lilly a percentage of any cash payments received in respect of any sub-licence of the licensed IP."
Hemo now own the building, lock stock and barrel. They can now sub licence CDX for AML, they can sublicence for ALL, for CLL, for Lupus, for whatever.
If Eli want to take it forward with Hemo for AML then they will RNS that separately and detail the clinical trial stages which is what I fully expect to happen next.
Hemo are listening. They were asked to stop doing massive RNS's with everything in one, Well this is a partial RNS and quite short, bite size.